How to Help Your Patients Find Apomorphine in Stock: A Provider's Guide

When a patient with advanced Parkinson's disease calls your office in distress because their specialty pharmacy is out of apomorphine, every minute matters. "Off" episodes can be debilitating and dangerous, and gaps in apomorphine supply can rapidly escalate into a medical emergency. This guide gives clinicians a concrete, replicable workflow for helping patients locate apomorphine stock quickly—and for preventing these gaps before they happen.

Why Apomorphine Access Problems Fall Back on Your Office

Unlike most outpatient medications, apomorphine requires a specialized distribution chain—specialty pharmacies, prior authorization, and patient hub enrollment. When a link in that chain breaks, patients often have nowhere else to turn but your office. Your clinic may receive frantic calls when:

A patient's specialty pharmacy runs out of stock and has no estimated restock date

Insurance PA denial delays refill processing

A patient moves and their new insurance plan's preferred pharmacy doesn't carry apomorphine

A new patient is newly prescribed Onapgo and the onboarding process is taking longer than expected

Step 1: Establish a Short List of Preferred Specialty Pharmacies

Your practice should maintain a current, verified list of specialty pharmacies in your geographic area that regularly stock apomorphine. Call each pharmacy at least twice a year to confirm they carry it and update your list. The following specialty pharmacy chains commonly stock apomorphine:

Walgreens Specialty Pharmacy (separate from retail Walgreens)

CVS Specialty

Accredo (Express Scripts specialty division; mail-order available)

Optum Rx Specialty

Hospital-system specialty pharmacies (often have reliable stock if they see significant neurology volume)

Step 2: Direct Patients to the Supernus Support Line

Supernus Pharmaceuticals operates a dedicated patient and provider support line for Apokyn and Onapgo. The number is 877-727-6596. The Supernus Support team can:

Identify specialty pharmacies in the patient's area with current stock

Assist with PA initiation and appeals

Connect patients with financial assistance or the patient assistance program

Facilitate Onapgo hub enrollment and nurse training support

Providing this number directly to patients—including in their discharge paperwork and post-visit instructions—can reduce the burden on your office staff when supply issues arise.

Step 3: Recommend medfinder for Real-Time Pharmacy Stock Lookup

medfinder is a service that calls pharmacies on behalf of patients to check which ones have a specific medication in stock. For apomorphine patients—who often face specialty pharmacy inventory gaps—recommending medfinder can eliminate hours of frustrated phone calls. The patient enters their medication, dosage, and zip code; medfinder makes the calls; and results are texted to the patient.

Consider listing medfinder in your standard patient handouts for all specialty medication prescriptions. It is particularly valuable for Parkinson's patients who may have mobility limitations that make extensive phone research difficult.

Step 4: Build a Pre-Approved Bridge Plan into Every Apomorphine Chart

For every patient on apomorphine, document a specific bridge plan in the chart. This should specify what action to take if apomorphine is unavailable for 24–48 hours. Options may include:

Increasing carbidopa/levodopa frequency or dose temporarily

Switching to or adding an oral dopamine agonist (pramipexole, ropinirole) for background control

Adding a MAO-B inhibitor (rasagiline, safinamide) to extend levodopa effect

Criteria for emergency department presentation if symptoms become severe

Having this plan pre-documented allows nursing staff to provide guidance to patients without requiring a physician to call back for each access disruption—an important efficiency gain in high-volume neurology practices.

Step 5: Proactively Manage Prior Authorization Timelines

Most PA approvals for apomorphine last 12 months. Build a tickler system in your EHR to flag patients at 10 months post-approval for early re-authorization. Submitting the renewal before the current PA expires prevents the coverage lapse that is one of the most common causes of apomorphine access disruption.

For an overview of the current apomorphine supply landscape, see our post on what providers need to know about the apomorphine shortage in 2026.